论文部分内容阅读
据WebMD网站近期披露,一项小型临床试验研究发现,一在研药物(未透露药名)可通过与肿瘤细胞表面一种叫做PD-L1的蛋白结合而激发机体免疫系统攻击肿瘤细胞,致使其他疗法治疗无效的癌症患者体内肿瘤缩小。
According to a recent WebMD website, a small clinical trial found that a drug under study (without disclosing the drug’s name) can stimulate the body’s immune system to attack tumor cells by binding to a protein called PD-L1 on the surface of tumor cells, causing other Tumors are shrinking in patients with ineffective therapies.